GLUCOTRACK INC

GCTKNASDAQ

🏆 #4076 by market capUS Equity

$0.37▼ $0.03 (−7.77%)

🌙 After hours$0.38▲ 2.29%Regular close · extended-hours price shown

1h—

24h▼ 7.8%

7d—

14d—

30d—

1y—

🏦Market Cap

$3M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

41.5x

Expensive

Otter Score

Weak

No chart data available for GCTK.

Trading Snapshot

Day Range: $0.37 – $0.38
52-Week Range: $0.25 – $14.14
Volume: $3.19B
Avg Volume: $2.28B
Shares Outstanding: 7.7M
Next Earnings: Sep 17, 2026

Fundamentals Snapshot

Annual Revenue: $69,183
Last Q Revenue: $18,062
P/E Ratio: —
P/S Ratio: 41.5x
EPS (TTM): $-20.88
Dividend Yield: —

Why Investors Own GCTK

✓High-growth profile — revenue up +0.1% YoY with expanding US Equity exposure.
✓Healthy economics — 30% gross margin and 12% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$69,183▼ −2.3% YoY

Gross Margin (TTM)

30.4%▲ +1.7% YoY

Operating Income (TTM)

$14,667▼ −2.3% YoY

Free Cash Flow (TTM)

$8,233▼ −2.3% YoY

About GLUCOTRACK INC

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

🦦